Madelung's disease

J Clin Endocrinol Metab. 2012 Sep;97(9):3012-3. doi: 10.1210/jc.2012-1649. Epub 2012 Jun 14.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Cholesterol / blood
  • Diabetes Complications / drug therapy
  • Diabetes Complications / etiology
  • Dyslipidemias / drug therapy
  • Dyslipidemias / etiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Lipomatosis, Multiple Symmetrical / complications
  • Lipomatosis, Multiple Symmetrical / diagnosis
  • Lipomatosis, Multiple Symmetrical / drug therapy*
  • Lipoproteins, HDL / blood
  • Lipoproteins, LDL / blood
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents
  • Insulin
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Cholesterol